Alfresa Holdings Corporation (JP:2784)
:2784
2784 Stock Chart & Stats
¥2523.00
-¥11.50(-0.53%)
At close: 4:00 PM EST
¥2523.00
-¥11.50(-0.53%)
Day’s Range― - ―
52-Week Range¥1,897.00 - ¥2,685.50
Previous CloseN/A
Volume412.80K
Average Volume (3M)354.02K
Market Cap
¥496.25B
Enterprise Value¥294.76B
Total Cash (Recent Filing)¥180.61B
Total Debt (Recent Filing)¥30.60B
Price to Earnings (P/E)5.4
Beta0.68
Next Earnings
May 19, 2026EPS Estimate
37.38Next Dividend Ex-DateN/A
Dividend Yield2.69%
Share Statistics
EPS (TTM)112.56
Shares Outstanding191,300,000
10 Day Avg. Volume331,350
30 Day Avg. Volume354,016
Financial Highlights & Ratios
PEG Ratio-3.35
Price to Book (P/B)0.81
Price to Sales (P/S)0.13
P/FCF Ratio-36.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)170.5
Revenue Forecast (FY)¥3.15T
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Balance SheetA debt-to-equity ratio of 0.07 indicates minimal financial leverage, reducing solvency and refinancing risk. This durable strength supports funding working capital needs in distribution, underpins investment in logistics, and preserves strategic optionality during industry cycles.
Stable, Essential Wholesaling Business ModelCore earnings derive from pharmaceutical wholesaling and supply-chain services, a structurally stable, mission-critical function for healthcare providers. Long-term demand and contractual relationships with hospitals, clinics and pharmacies create recurring flows and high customer stickiness.
Consistent Revenue Growth And ScaleSteady revenue growth around mid-single digits indicates ongoing market penetration and scale in distribution. Over months, this supports purchasing leverage, negotiated supplier terms, and marginal margin improvement potential from higher throughput and fixed-cost absorption.
Bears Say
Very Thin Profitability MarginsNet margin under 1% and low gross margin leave limited buffer against cost inflation or pricing pressure. For a distribution business, thin profitability constrains capacity to absorb shocks, invest in value-added services, or sustainably increase returns to shareholders over time.
Weak Cash Conversion / Negative Free Cash FlowA sharp drop to negative free cash flow and an OCF-to-net income ratio of 0.21 indicate difficulty turning accounting profits into spendable cash. This durable weakness restricts reinvestment in logistics, tech or M&A, and may force reliance on external funding despite low leverage.
Modest Return On EquityAn ROE near 5.7% is modest for a capital-intensive distributor; it signals limited ability to generate high returns on shareholder capital. Over the medium term this may slow equity compounding, constrain dividend growth, and reduce attractiveness versus higher-return deployment alternatives.
Alfresa Holdings News
2784 FAQ
What was Alfresa Holdings Corporation’s price range in the past 12 months?
Alfresa Holdings Corporation lowest stock price was ¥1897.00 and its highest was ¥2685.50 in the past 12 months.
What is Alfresa Holdings Corporation’s market cap?
Alfresa Holdings Corporation’s market cap is ¥496.25B.
When is Alfresa Holdings Corporation’s upcoming earnings report date?
Alfresa Holdings Corporation’s upcoming earnings report date is May 19, 2026 which is in 42 days.
How were Alfresa Holdings Corporation’s earnings last quarter?
Alfresa Holdings Corporation released its earnings results on Feb 10, 2026. The company reported ¥112.56 earnings per share for the quarter, beating the consensus estimate of ¥65.448 by ¥47.112.
Is Alfresa Holdings Corporation overvalued?
According to Wall Street analysts Alfresa Holdings Corporation’s price is currently Overvalued.
Does Alfresa Holdings Corporation pay dividends?
Alfresa Holdings Corporation pays a Semiannually dividend of ¥34 which represents an annual dividend yield of 2.69%. See more information on Alfresa Holdings Corporation dividends here
What is Alfresa Holdings Corporation’s EPS estimate?
Alfresa Holdings Corporation’s EPS estimate is 37.38.
How many shares outstanding does Alfresa Holdings Corporation have?
Alfresa Holdings Corporation has 191,300,000 shares outstanding.
What happened to Alfresa Holdings Corporation’s price movement after its last earnings report?
Alfresa Holdings Corporation reported an EPS of ¥112.56 in its last earnings report, beating expectations of ¥65.448. Following the earnings report the stock price went down -0.311%.
Which hedge fund is a major shareholder of Alfresa Holdings Corporation?
Currently, no hedge funds are holding shares in JP:2784
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Alfresa Holdings Corporation
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.
Technical Analysis
Medipal Holdings
―
Sundrug Co
―
Sugi Holdings Co
―
Suzuken Co
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―
Options Prices
Currently, No data available
---